Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Verona Pharma plc (VRNA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
05/16/2023 SC 13D/A ORBIMED ADVISORS LLC reports a 4.8% stake in Verona Pharma plc
05/11/2023 144 Form 144 - Report of proposed sale of securities:
05/09/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update"
05/03/2023 144 Form 144 - Report of proposed sale of securities:
05/01/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "VERONA PHARMA PLC SECOND AMENDED AND RESTATED 2017 INCENTIVE AWARD PLAN"
04/25/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
04/20/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/21/2023 ARS Form ARS - Annual Report to Security Holders:
03/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/07/2023 F-6EF Form F-6EF - Registration of American Depository Receipt shares, immediately effective:
03/07/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
03/07/2023 10-K Annual Report for the period ended December 31, 2022
03/07/2023 8-K Results of Operations and Financial Condition  Interactive Data
Docs: "Verona Pharma Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update"
02/14/2023 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 10% stake in Verona Pharma plc
02/09/2023 SC 13G/A Access Industries Holdings LLC reports a 5.4% stake in Verona Pharma plc
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/27/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/20/2022 8-K Quarterly results
11/15/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
10/17/2022 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "Lenders and Commitments"
09/07/2022 SC 13D/A Growth Equity Opportunities Fund IV, LLC reports a 7.9% stake in Verona Pharma plc
08/12/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/11/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNDERWRITING AGREEMENT",
"Verona Pharma plc"
08/11/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/11/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/10/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/09/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy